查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866550

全球药物治疗管理市场－2025-2030年预测

Global Medication Management Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球药物治疗管理市场预计将从 2025 年的 37.95 亿美元成长到 2030 年的 68.51 亿美元，复合年增长率为 12.54%。

药物治疗管理市场是医疗保健领域的关键板块，专注于以患者为中心的系统，旨在优化安全、有效和适当的药物治疗。这些系统简化了临床操作，确保药物的准确给药和患者依从性。日益复杂的治疗方法、慢性病盛行率的上升以及技术的进步正在推动市场发展，但高昂的实施成本仍然是一大挑战。

本报告检验了当前药物治疗管理市场的需求、供应和销售趋势，以及影响该市场发展的最新动态。报告全面分析了关键驱动因素、阻碍因素和机会，并详细说明了区域产业趋势、政策和法规，以帮助相关人员深入了解法规结构和市场动态。

我们的竞争情报是基于广泛的二手研究，包括产业协会调查、分析师报告、投资者报告、新闻稿和学术期刊，旨在识别主要企业及其收入贡献。市场规模采用自下而上和自上而下的方法计算，并透过来自全球药物治疗管理价值链相关人员的第一手资讯检验。我们全面的市场分析整合了各种资讯来源和专有资料集，并运用资料三角测量技术，提供准确的市场区隔和预测。我们透过分析叙述、图表和图形呈现洞察，以帮助读者有效率地理解。 2024年全球市场规模约26亿美元，预计2030年将达到58亿美元，复合年增长率（CAGR）为14.3%。主要企业包括Genoa Healthcare、Becton, Dickinson & Company、SinfoniaRx（Tabula Rasa Healthcare旗下公司）、CSAM Health AS、 Honeywell International、GE Healthcare、Talyst LLC、Cerner Corporation、OptumRx和McKesson Corporation。

主要亮点

  • 复杂治疗方法：先进治疗方法的出现推动了对高效能药物治疗管理系统的需求。
  • 慢性疾病：慢性疾病的日益普及（到 2024 年将影响全球 60% 的成年人）正在推动市场成长。
  • 技术进步：远距药物治疗管理和玫瑰花结系统等创新正在创造成长机会。
  • 成本障碍：高昂的安装和维修成本阻碍了其普及，尤其是在小规模的医疗机构。

成长要素

慢性病发病率的上升（预计2024年全球整体成长5%）对药物治疗管理提出了更高的要求，以确保病患监测与营运效率。医疗保健资讯科技的日益普及，尤其是在北美地区（预计2024年数位医疗投资将成长10%），正在推动市场扩张。

阻碍因素

综合医疗保健系统的实施涉及高昂的初始成本（平均50万美元）以及持续的维护成本，这限制了其在小规模医疗机构中的应用。与现有医疗保健系统的整合挑战增加了实施的复杂性。新兴市场技术专长的缺乏也阻碍了其进一步的扩充性。

细分市场分析

按软体类型划分：库存管理系统由于其在最大限度减少资源浪费方面主导的作用，预计到2024年将占据35%的市场份额。临床决策支援系统由于其在提高患者安全方面发挥的作用，正在快速成长。

按交付方式划分：云端基础的解决方案处于主导，提供扩充性和远端访问，而本地部署系统在对安全性要求较高的环境中继续蓬勃发展。

按最终用户划分：医院占比最大，但随着远端医疗的发展趋势，药房和居家医疗领域的采用率正在不断提高。

区域分析

到2024年，北美将占据42%的市场份额，这主要得益于美国医疗保健产业的高IT应用率以及150亿美元的数位医疗投资。亚太地区将以16%的复合年增长率成长，主要受中国和印度慢性病患病率上升以及医疗保健现代化进程的推动。欧洲则凭藉其支持性的数位医疗政策取得了进展。

本报告为业内人士提供关于市场趋势、监管环境和竞争动态的关键洞察。报告重点阐述了先进治疗方法和数位医疗整合领域的机会，同时也探讨了成本和整合的挑战。严谨的调查方法，结合一手和二手数据，确保了预测的可靠性，使相关人员能够理解复杂的市场格局，并优先考虑在这一重要医疗保健领域的投资。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球药物治疗管理市场（依软体类型划分）

  • 介绍
  • 电脑化医师医嘱输入系统（CPOE）
  • 临床决策支援系统（CDSS）
  • 电子药物管理记录（eMAR）
  • 库存管理和分发管理

6. 全球药物治疗管理市场依给药方式划分

  • 介绍
  • 本地部署
  • 云端基础的

7. 全球药物治疗管理市场（依最终用户划分）

  • 介绍
  • 医院和诊所
  • 药局
  • 门诊手术中心
  • 长期照护机构

8. 全球药物治疗管理市场（按地区划分）

  • 介绍
  • 北美洲
    • 依软体类型
    • 透过供应方法
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依软体类型
    • 透过供应方法
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依软体类型
    • 透过供应方法
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 依软体类型
    • 透过供应方法
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依软体类型
    • 透过供应方法
    • 最终用户
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Optum United Health
  • Becton, Dickinson and Company
  • Omda AS
  • Honeywell International Inc.
  • GE Healthcare Technologies, Inc.
  • Talyst, LLC（Swisslog Healthcare）
  • Oracle Health
  • McKesson Corporation
  • Omnicell, Inc.
  • Cardinal Health Inc.
  • Baxter International, Inc.

第十二章 分析方法

简介目录
Product Code: KSI061612027

The Global Medication Management Market is set to grow from USD 3.795 billion in 2025 to USD 6.851 billion by 2030, driven by a 12.54% CAGR.

The medication management market is a critical segment of healthcare, focusing on patient-centered systems to optimize safe, effective, and appropriate drug therapy. These systems streamline clinical operations, ensuring accurate medication administration and adherence. The market is driven by the rise of complex therapies, increasing chronic disease prevalence, and technological advancements, though high implementation costs pose challenges.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the medication management market. It provides a comprehensive analysis of key drivers, restraints, and opportunities, detailing industry trends, policies, and regulations across geographical regions to equip stakeholders with insights into the regulatory framework and market dynamics.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research, including industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall sector and key segments was determined using bottom-up and top-down methodologies, validated with primary inputs from stakeholders in the global medication management value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting. Insights are presented through analytical narratives, charts, and graphics for efficient comprehension. The global market was valued at approximately USD 2.6 billion in 2024 and is projected to reach USD 5.8 billion by 2030, growing at a CAGR of 14.3%. Key players profiled include Genoa Healthcare, Becton, Dickinson and Company, Sinfonia Rx (A Tabula Rasa Healthcare Company), CSAM Health AS, Honeywell International Inc., GE Healthcare, Talyst, LLC, Cerner Corporation, OptumRx, and McKesson Corporation.

Key Highlights

  • Complex Therapies: Emergence of advanced therapies drives demand for efficient medication management systems.
  • Chronic Diseases: Rising prevalence of chronic conditions, affecting 60% of adults globally in 2024, fuels market growth.
  • Technological Advancements: Innovations like remote medication management and rosette systems create growth opportunities.
  • Cost Barriers: High implementation and maintenance costs hinder adoption, particularly for smaller healthcare facilities.

Growth Drivers

The rise in chronic diseases, with global cases increasing by 5% in 2024, necessitates robust medication management to ensure adherence and safety. An aging population, projected to reach 1.5 billion by 2050, increases demand for systems to manage complex medication regimens. Technological advancements, such as remote medication management systems introduced by McKesson in 2024, enhance patient monitoring and operational efficiency. Growing healthcare IT adoption, particularly in North America, with a 10% increase in digital health investments in 2024, supports market expansion.

Restraints

High implementation costs, averaging USD 500,000 for comprehensive systems, and ongoing maintenance expenses limit adoption in smaller healthcare settings. Integration challenges with legacy healthcare systems increase deployment complexity. Limited technical expertise in emerging markets further restricts scalability.

Segmentation Analysis

By Software Type: Inventory management systems dominate with a 35% share in 2024, driven by their role in minimizing resource wastage. Clinical decision support systems grow rapidly for enhanced patient safety.

By Delivery Mode: Cloud-based solutions lead, offering scalability and remote access, while on-premise systems persist in secure environments.

By End-User: Hospitals command the largest share, with pharmacies and homecare settings expanding due to telehealth trends.

Regional Analysis

North America holds a 42% market share in 2024, driven by high IT adoption in the U.S. healthcare sector and investments of USD 15 billion in digital health. Asia Pacific grows at a 16% CAGR, fueled by rising chronic disease prevalence and healthcare modernization in China and India. Europe advances through supportive digital health policies.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in advanced therapies and digital health integration while addressing cost and integration challenges. The rigorous methodology, blending primary and secondary data, ensures reliable projections, enabling stakeholders to navigate complexities and prioritize investments in this essential healthcare sector.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Software Type

  • Computerized Physician Order Entry (CPOE)
  • Clinical Decision Support Systems (CDSS)
  • Electronic Medication Administration Records (eMAR)
  • Inventory & Dispensing Management

By Delivery Mode

  • On-Premise
  • Cloud-Based

By End-User

  • Hospitals & Clinics
  • Pharmacies
  • Ambulatory Surgical Centers
  • Long-Term Care Facilities

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICATION MANAGEMENT MARKET BY SOFTWARE TYPE

  • 5.1. Introduction
  • 5.2. Computerized Physician Order Entry (CPOE)
  • 5.3. Clinical Decision Support Systems (CDSS)
  • 5.4. Electronic Medication Administration Records (eMAR)
  • 5.5. Inventory & Dispensing Management

6. GLOBAL MEDICATION MANAGEMENT MARKET BY DELIVERY MODE

  • 6.1. Introduction
  • 6.2. On-Premise
  • 6.3. Cloud-Based

7. GLOBAL MEDICATION MANAGEMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Pharmacies
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Long-Term Care Facilities

8. GLOBAL MEDICATION MANAGEMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Software Type
    • 8.2.2. By Delivery Mode
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Software Type
    • 8.3.2. By Delivery Mode
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Software Type
    • 8.4.2. By Delivery Mode
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East & Africa
    • 8.5.1. By Software Type
    • 8.5.2. By Delivery Mode
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Software Type
    • 8.6.2. By Delivery Mode
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Optum United Health
  • 10.2. Becton, Dickinson and Company
  • 10.3. Omda AS
  • 10.4. Honeywell International Inc.
  • 10.5. GE Healthcare Technologies, Inc.
  • 10.6. Talyst, LLC (Swisslog Healthcare)
  • 10.7. Oracle Health
  • 10.8. McKesson Corporation
  • 10.9. Omnicell, Inc.
  • 10.10. Cardinal Health Inc.
  • 10.11. Baxter International, Inc.

11. RESEARCH METHODOLOGY